Header Logo

Connection

KEVIN ERICKSON to Humans

Back to Details
This is a "connection" page, showing publications KEVIN ERICKSON has written about Humans.
KEVIN ERICKSON
Connection Strength
0.682
Humans
  1. Facility Closures and Distance Traveled to Receive Dialysis Care in the United States. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1610-1612.
    View in: PubMed
    Score: 0.018
  2. Considering the Effects of a Recent US Supreme Court's Ruling on Dialysis Care Costs. Clin Ther. 2023 03; 45(3):272-276.
    View in: PubMed
    Score: 0.018
  3. In-center hemodialysis unit patient experience with telehealth. Hemodial Int. 2023 04; 27(2):193-196.
    View in: PubMed
    Score: 0.018
  4. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.018
  5. The US Supreme Court and Future of Financing Dialysis Care. Clin J Am Soc Nephrol. 2023 02 01; 18(2):273-275.
    View in: PubMed
    Score: 0.018
  6. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.017
  7. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.017
  8. Market Consolidation and Innovation in US Dialysis. Adv Chronic Kidney Dis. 2022 01; 29(1):65-75.
    View in: PubMed
    Score: 0.016
  9. The beneficial effect of providing kidney transplantation information on transplantation status differs between for-profit and nonprofit dialysis centers. Transpl Int. 2021 12; 34(12):2644-2668.
    View in: PubMed
    Score: 0.016
  10. How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets? JAMA Health Forum. 2021 11 02; 2(11):e213378.
    View in: PubMed
    Score: 0.016
  11. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.016
  12. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.016
  13. One Step Closer to Developing a National Dialysis Registry in China. Am J Kidney Dis. 2021 06; 77(6):866-868.
    View in: PubMed
    Score: 0.016
  14. ACOs and Bending the Cost Curve for Health Care Spending for People with Kidney Failure. Clin J Am Soc Nephrol. 2020 12 07; 15(12):1699-1701.
    View in: PubMed
    Score: 0.015
  15. Payer Mix Among Patients Receiving Dialysis. JAMA. 2020 09 01; 324(9):900-901.
    View in: PubMed
    Score: 0.015
  16. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.014
  17. Physician reimbursement for outpatient dialysis care: Past, present, and future. Semin Dial. 2020 01; 33(1):68-74.
    View in: PubMed
    Score: 0.014
  18. Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020 01; 33(1):90-99.
    View in: PubMed
    Score: 0.014
  19. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.014
  20. Safety-Net Care for Maintenance Dialysis in the United States. J Am Soc Nephrol. 2020 02; 31(2):424-433.
    View in: PubMed
    Score: 0.014
  21. Do Salaried Physician Specialists Provide Less Care to Patients With Chronic Disease? JAMA Netw Open. 2019 11 01; 2(11):e1914885.
    View in: PubMed
    Score: 0.014
  22. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
    View in: PubMed
    Score: 0.014
  23. Expanded Prospective Payment System and Use of and Outcomes with Home Dialysis by Race and Ethnicity in the United States. Clin J Am Soc Nephrol. 2019 08 07; 14(8):1200-1212.
    View in: PubMed
    Score: 0.014
  24. The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: moving beyond statins. Kidney Int. 2019 07; 96(1):22-25.
    View in: PubMed
    Score: 0.014
  25. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions. JAMA Netw Open. 2019 05 03; 2(5):e193987.
    View in: PubMed
    Score: 0.014
  26. Integrated Care in ESKD: A Perspective of Nephrologists. Clin J Am Soc Nephrol. 2019 03 07; 14(3):451-453.
    View in: PubMed
    Score: 0.013
  27. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.013
  28. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.013
  29. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
    View in: PubMed
    Score: 0.013
  30. Making Policy in the Dark: The Use of Activated Vitamin D Under Bundled Payments for Dialysis?Care. Am J Kidney Dis. 2018 08; 72(2):161-163.
    View in: PubMed
    Score: 0.013
  31. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.013
  32. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.013
  33. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.012
  34. Home Alone: Does Modality Matter? Revisiting Hospital Readmissions in Dialysis. Am J Kidney Dis. 2017 07; 70(1):1-3.
    View in: PubMed
    Score: 0.012
  35. Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis. 2017 Feb; 69(2):237-246.
    View in: PubMed
    Score: 0.011
  36. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.011
  37. Measuring comorbidity in patients receiving dialysis: can we do better? Am J Kidney Dis. 2015 Nov; 66(5):731-4.
    View in: PubMed
    Score: 0.010
  38. Overlooked care transitions: an opportunity to reduce acute care use in ESRD. Clin J Am Soc Nephrol. 2015 Mar 06; 10(3):347-9.
    View in: PubMed
    Score: 0.010
  39. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.010
  40. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.010
  41. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.010
  42. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2014 Jan 21; 160(2):143.
    View in: PubMed
    Score: 0.009
  43. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2013 Sep 17; 159(6):382-9.
    View in: PubMed
    Score: 0.009
  44. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
    View in: PubMed
    Score: 0.009
  45. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.009
  46. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81.
    View in: PubMed
    Score: 0.009
  47. The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
    View in: PubMed
    Score: 0.008
  48. Geographic Dialysis Facility Density and Early Dialysis Initiation. JAMA Netw Open. 2024 Jan 02; 7(1):e2350009.
    View in: PubMed
    Score: 0.005
  49. Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline. J Gen Intern Med. 2023 Nov; 38(14):3198-3208.
    View in: PubMed
    Score: 0.005
  50. Optimal Care for Kidney Health: Development of a Merit-based Incentive Payment System (MIPS) Value Pathway. J Am Soc Nephrol. 2023 08 01; 34(8):1315-1328.
    View in: PubMed
    Score: 0.005
  51. Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
    View in: PubMed
    Score: 0.004
  52. Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. J Am Soc Nephrol. 2020 03; 31(3):602-614.
    View in: PubMed
    Score: 0.004
  53. Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698.
    View in: PubMed
    Score: 0.004
  54. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.003
  55. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.003
  56. Market Competition and Health Outcomes in Hemodialysis. Health Serv Res. 2018 10; 53(5):3680-3703.
    View in: PubMed
    Score: 0.003
  57. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.003
  58. A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
    View in: PubMed
    Score: 0.003
  59. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
    View in: PubMed
    Score: 0.003
  60. Federal Funding for Kidney Disease Research: A Missed Opportunity. Am J Public Health. 2016 Mar; 106(3):406-7.
    View in: PubMed
    Score: 0.003
  61. Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiol Drug Saf. 2014 May; 23(5):515-25.
    View in: PubMed
    Score: 0.002
  62. Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis. Am J Nephrol. 2011; 33(5):390-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.